Aibo Medical to Acquire 68.31% Stake in Demei Medical for RMB 683 Million to Expand into Sports Medicine

Gelonghux 25 February | Eyebright Medical (688050.SH) announced that the company plans to use acquisition loans and its own funds to acquire 68.31% of Delta Medical's equity at a transaction price of 683 million yuan. Delta Medical has been selected for the fourth batch of China's national high-value medical consumables procurement Group A, ranking among the top tier in the industry; it possesses extensive clinical expert resources, with a sales network covering China and overseas regions including Southeast Asia, Latin America, the Middle East, and Europe. There is a certain degree of synergy between Delta Medical and Eyebright Medical in product/R&D, manufacturing, and domestic and international sales channels.